User Fees: Should US FDA Incur Penalties For Missed Deadlines?
Executive Summary
Sen. Burr asks FDA whether fee revenue should be rebated for not meeting some PDUFA V goals.
You may also be interested in...
US FDA Still Waiting For Cures Money, Woodcock Says
When asked about Cures-related hiring, CDER Director says to her knowledge, no funding has been received yet.
US FDA Might Face Funding Penalty For Missing User-Fee Goals
Industry representatives support adding a provision to the user-fee agreements that would withdraw some taxpayer funding if the agency does not meet its deliverables.
US FDA Might Face Funding Penalty For Missing User Fee Goals
Industry representatives support adding a provision to the user fee agreements that would withdraw some taxpayer funding if the agency does not meet its deliverables.